Lessons on Two Key Trends Driving Global Business:
(1) Changing Populations and Digital Technology and (2) Brexit – Calm Before the Storm?

Morrison & Foerster Women in Business Seminar

10/20/2016 03:00 p.m. - 06:00 p.m.

Japan and Pharmaceutical + Medical Device

Shin-Marunouchi Building
29th Floor
5-1, Marunouchi 1-Chome
Chiyoda-ku, Tokyo
Japan 100-6529

Rika SaekiKyoko SatoYemi TépéLouise C. Stoupe, and Aramide O. Fields


This seminar will focus on the new legal and economic developments trends and challenges in the region in the following two important areas driving global business:

Lessons from The Pharmaceutical Industry: Dealing With Change

The pharmaceutical industry has been undergoing dramatic transformations to deal with changes in the population while also adapting to the integration of digital technology. In this seminar, we will have two professionals from the pharmaceutical industry discuss the transition from traditional technology to the electronic era.  They will also provide an exciting opportunity to learn about how the changing population is changing the pharmaceutical industry. This is one of the fastest growing industries globally and the way that it is expanding into areas beyond its traditional borders such as digital technology, provides useful lessons for professionals in all industries.  

Brexit - Calm Before the Storm?

In the immediate aftermath of the 23 June Brexit vote, the doom and gloom predictions of the “Remain” campaigners appeared to have come true. On 24 June, the pound plunged dramatically against the US dollar and the euro. Volatility in the global markets had caused $2 trillion of losses. The International Monetary Fund and the credit rating agencies lowered their outlook for the UK which lost its prized AAA rating. However, recent data shows an apparent rebounding after the initial shock of the Brexit vote. The UK economy appears to be defying predictions of a recession as consumers are actively spending again, sales across various industry sectors are up and the world markets seem to be calm. But Japan’s recent message to the UK and the EU exposes this false sense of security and warns of the uncertainty, complexity and disruption to come.


  • Mariko Mimura
    Vice President, General Counsel and Board Member of GlaxoSmithKlein K.K.
  • Hiromi Furushima
    Corporate Officer, General Counsel, Head of Legal/IP department of Novartis Pharma K.K.
  • Yemi Tépé
    Partner, Morrison & Foerster Singapore office
  • Rika Saeki
    Of Counsel, Morrison & Foerster / Ito & Mitomi Tokyo office
  • Aramide Fields
    Associate, Morrison & Foerster / Ito & Mitomi Tokyo office
  • Kyoko Sato
    Associate, Ito & Mitomi / Morrison & Foerster Tokyo office
  • Louise Stoupe
    Partner, Morrison & Foerster / Ito & Mitomi Tokyo office


Find MoFo Info

Email Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

©1996-2016 Morrison & Foerster LLP. All rights reserved.